Correction: Real-world experience with family beliefs and organizational and communication management in Colombian parents of children with leukemia: a qualitative study.

Spinal cord stimulation (SCS) is a widely used treatment for chronic intractable neuropathic pain that has not responded to conservative management []. Before permanent implantation, a temporary trial is required to determine eligibility and reduce risks, as recommended by agencies like the Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), commercial insurers, and professional society guidelines [,]. During the trial, patients evaluate pain relief, functional improvement, and response to stimulation while testing programming options. Before undergoing an SCS trial, patients complete thorough clinical screening including preoperative imaging, laboratory workup, and medical clearance to identify factors that may affect outcomes and ultimate progression to trial. Variables such as elevated body mass index (BMI), smoking, and opioid use have been associated with reduced SCS implant success []. In addition to imaging and medical evaluation, formal psychological assessments are used to analyze psychosocial risk factors, evaluate patient experience of pain, and predict therapy outcomes prior to trial. These evaluations, conducted by licensed mental health professionals, are required by Medicare [].